Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 9/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15822013 | 1.00 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL17289535 | 1.00 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL14645417 | 1.00 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL30204751 | 1.00 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL15961536 | 0.94 | CYP3A4 (0.51) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL17223573 | 0.92 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL15572502 | 0.92 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL29367541 | 0.92 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL15825100 | 0.92 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 | |
| SCHEMBL20337001 | 0.91 | CYP3A4 (0.43) | CYP3A4CYP2C9CYP2C19CYP19A1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4346412-A1 | FUNGICIDAL COMPOSITION CONTAINING OXADIAZOLE COMPOUNDS | PI Industries Ltd. (IN) | 2024-04-10 | — | — | EP | claimed |
| CN-117396074-A | Fungicidal compositions containing oxadiazole compounds | PI工业有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-116801720-A | Novel agrochemical compositions comprising 3-substituted benzamidine compounds and uses thereof | 皮埃企业有限公司 | 2023-09-22 | — | — | CN | claimed |
| EP-4175476-A1 | A PESTICIDALLY ACTIVE MIXTURE COMPRISING THIETANYLOXY COMPOUND, OXIDES OR SALTS THEREOF | PI Industries Ltd. (IN) | 2023-05-10 | — | — | EP | claimed |
| EP-4167740-A1 | ACTIVE COMPOUND COMBINATIONS | Bayer Aktiengesellschaft (DE) | 2023-04-26 | — | — | EP | claimed |
| CN-115955916-A | Active compound combinations | 拜耳公司 | 2023-04-11 | — | — | CN | claimed |
| EP-4156936-A1 | ACTIVE COMPOUND COMBINATIONS | Bayer Aktiengesellschaft (DE) | 2023-04-05 | — | — | EP | claimed |
| EP-4135523-A1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | Bayer Aktiengesellschaft (DE) | 2023-02-22 | — | — | EP | claimed |
| EP-4135519-A1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | Bayer Aktiengesellschaft (DE) | 2023-02-22 | — | — | EP | claimed |
| EP-4135518-A1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | Bayer Aktiengesellschaft (DE) | 2023-02-22 | — | — | EP | claimed |
| CN-115697059-A | Active compound combinations | 拜耳公司 | 2023-02-03 | — | — | CN | claimed |
| CN-115551352-A | Active compound combinations and fungicide compositions comprising them | 拜耳公司 | 2022-12-30 | — | — | CN | claimed |
| WO-2022249074-A1 | FUNGICIDAL COMPOSITION CONTAINING OXADIAZOLE COMPOUNDS | PI INDUSTRIES LTD. (IN) | 2022-12-01 | — | — | WO | claimed |
| EP-4037485-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING FATTY ACIDS | Bayer Aktiengesellschaft (DE) | 2022-08-10 | — | — | EP | claimed |
| CN-114760842-A | Active substance combinations comprising fatty acids | 拜耳公司 | 2022-07-15 | — | — | CN | claimed |
| US-20260144250-A1 | SOLVENT-FREE FORMULATIONS OF LOW-MELTING ACTIVE INGREDIENTS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2026-05-28 | — | — | US | disclosed |
| CN-116969925-B | Heteroaryl-triazole compounds | BAYER AG (DE) | 2026-05-26 | — | — | CN | disclosed |
| WO-2022023931-A1 | A PESTICIDALLY ACTIVE MIXTURE COMPRISING PYRAZOLOPYRIDINE ANTHRANILAMIDE COMPOUND, OXIDES OR SALTS THEREOF | PI INDUSTRIES LTD (IN) | 2022-02-03 | — | — | WO | disclosed |
| CN-114007420-A | High diffusivity ULV formulations for fungicides | 拜耳公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114007421-A | Absorption-promoting ULV formulations | 拜耳公司 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144250-A1 | SOLVENT-FREE FORMULATIONS OF LOW-MELTING ACTIVE INGREDIENTS | FOXM1, CSDE1, RCC1 | CYP3A4 304/4885CYP2C9 269/4885CYP2C19 284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.